MedPath

Novel Therapy of PAD by Combined Transplantation of BMCs

Phase 1
Conditions
Peripheral Arterial Disease
Registration Number
NCT00411840
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

We analyze the effects of combined intramuscular and intraarterial transplantation of BMCs in patients with PAD. BMCs were transplanted into the ischemic limb.

After 2 and 13 months walking distance and perfusion indices were monitored.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • severe limb ischemia
Exclusion Criteria
  • infectious disease
  • cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
ABI, walking distance, capillary-venous oxygen saturation, venous occlusion plethysmography
Secondary Outcome Measures
NameTimeMethod
feasibility

Trial Locations

Locations (1)

Heinrich-Heine-University

🇩🇪

Duesseldorf, Germany

© Copyright 2025. All Rights Reserved by MedPath